Orthofix hit with new FCPA investigation while under DPA

Medical equipment manufacturer Orthofix has notified the US Department of Justice and the Securities & Exchange Commission of bribery allegations related to a Brazilian subsidiary. In its latest SEC filing, the company said it is still under a three-year deferred prosecution agreement concerning a previous bribery offence in 2012 involving Mexican subsidiary Promeca.


Get unlimited access to all Global Investigations Review content